Sunday 11 October 2026 Export all XRN data to Excel Powerpack

Chiron Real Estate Inc.

XRN Real Estate Reit Healthcare Facilities

Chiron Real Estate Inc.’s revenue for fiscal 2025 (year ended December 2025) was $148.2 million, up 6.79% from fiscal 2024. In the quarter to June 2026, revenue grew 4.68%, EPS grew 9,660.0%, free cash flow fell 18.0% and total debt fell 9.53%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

33.59 0.51 −1.50%

Follow XRN

Alert me

Market cap: $494.3M
P/E: 9.0×
Fwd P/E: −23.9×
Dividend yield: 7.31%
F-score: 4/9
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 3.95

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	2	1	—	—	—	—	9	—	—	7	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 9.71%

Capital & Financial Ratios $m

Market Cap 494.27

Revenue 153.43

Net Income 62.73

Free Cash Flow 37.56

Net Debt 622.39

Current Ratio 0.59

Debt/Equity 0.93

P/E ratio 9.04

Fwd P/E (23.90)

P/S ratio 2.90

P/B ratio 0.96

Past 5Y EPS Growth —

This Y EPS Growth 428.85%

Next Y EPS Growth (154.22%)

Next Y revenue growth 4.18%

Next 5Y EPS Growth 16.23%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 0.07%

10-year low 10-year high

P/S against its own 10 years 5.21%

10-year low 10-year high

P/B against its own 10 years 15.94%

10-year low 10-year high

EV/Sales against its own 10 years 0.04%

10-year low 10-year high

Dividends

Payout Ratio 0.66

Annual Dividend Rate 2.46

Annual Dividend Yield 7.31%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	2.30	0.25 0.25 0.25 0.16 0.16 0.16 0.16 0.16 0.16
2025	3.30	1.05 0.75 0.75 0.75
2024	4.20	1.05 1.05 1.05 1.05
2023	4.20	1.05 1.05 1.05 1.05
2022	4.20	1.05 1.05 1.05 1.05
2021	5.13	1.03 1.03 1.03 1.03 1.03
2020	4.00	1.00 1.00 1.00 1.00
2019	4.00	1.00 1.00 1.00 1.00
2018	4.00	1.00 1.00 1.00 1.00
2017	4.20	1.00 1.00 0.20 1.00 1.00
2016	3.53	0.43 0.09 0.09 0.43 0.09 0.43 1.00 1.00

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	7	9	12	13
Receivables	—	—	—	—
Inventory	—	—	—	—
Other	—	—	—	—
	7	9	12	13

	2023	2024	2025	Q'26
Payables	13	16	18	21
ST’ Debt	—	—	—	—
Other	—	—	—	—
	39	31	19	22

Compound Annual Growth %

	10y	5y	3y
Sales	53.34%	9.60%	2.59%
Cash Flow	0.00%	16.35%	(1.29%)
Earnings	0.00%	0.00%	0.00%
Book Value	0.00%	2.98%	(6.53%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	38	40	—	—	—
’25	35	38	37	38	148
’24	35	34	34	35	139
’23	36	36	36	33	141
’22	32	34	35	36	137
’21	27	28	30	30	116
’20	22	22	25	25	94

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	13	23	—	—	—
’25	12	22	18	22	74
’24	14	19	16	21	70
’23	16	18	17	18	68
’22	16	23	18	18	77
’21	15	18	19	17	69
’20	12	12	(5)	16	35

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	11	(20)	—	—	—
’25	(15)	(17)	18	29	15
’24	12	23	(8)	5	32
’23	19	80	23	15	137
’22	(9)	(53)	(17)	16	(62)
’21	(28)	(55)	(32)	(12)	(127)
’20	(56)	4	(66)	(65)	(184)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.06)	4.78	—	—	—
’25	0.15	(0.05)	(0.45)	(0.55)	(0.91)
’24	0.05	(0.25)	0.15	0.10	0.05
’23	0.05	0.90	0.25	(0.05)	1.15
’22	0.20	0.15	0.60	0.05	1.00
’21	0.15	0.20	0.30	0.30	0.95
’20	0.15	0.00	(1.10)	0.10	(0.85)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	17.90	39.25	31.70	43.30	34.90	62.00	35.05	40.20	37.15	29.05	Analyst estimates 2026–2028 Powerpack
	High	56.90	51.25	50.25	71.30	79.75	89.80	92.55	58.95	55.60	45.75
People
People	Employees	10	9	2	2	22	26	29	26	26	30
	Revenue/emp, $m	0.82	3.37	26.60	35.36	4.26	4.46	4.73	5.42	5.34	4.94
Income, $m
Income, $m	Revenue	8	30	53	71	94	116	137	141	139	148
	Gross margin, %	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
	EBT	(6)	0	15	10	(2)	18	20	22	7	(7)
	EBT margin, %	(77.37)	(0.29)	27.37	13.56	(2.67)	15.82	14.57	15.41	4.82	(4.64)
	Net income	(6)	0	15	10	(2)	18	20	22	7	(7)
	Depreciation	3	11	20	27	38	49	60	61	58	62
Per share, $
Per share, $	Revenue	4.41	7.73	12.11	10.44	10.13	9.56	10.49	10.76	10.52	11.08
	Earnings	(3.40)	(0.45)	1.75	0.50	(0.85)	0.95	1.00	1.15	0.05	(0.91)
	Cash flow	(1.16)	3.21	5.65	5.38	3.73	5.69	5.85	5.22	5.31	5.50
	Capex	(80.95)	(64.31)	(34.52)	(37.92)	(23.65)	(16.18)	(10.56)	5.25	(2.86)	(4.39)
	Free cash flow	(82.11)	(61.10)	(28.87)	(32.54)	(19.92)	(10.49)	(4.72)	10.47	2.45	1.11
	Book value	83.33	66.02	68.21	67.97	49.48	52.57	49.58	46.21	42.16	39.62
	Shares, m	2	4	4	7	9	12	13	13	13	13
Valuation, ×
Valuation, ×	P/E	0.00	0.00	26.15	132.30	0.00	93.42	47.05	47.83	772.00	0.00
	P/S	10.12	5.49	3.67	6.33	6.45	9.28	4.49	5.11	3.67	3.05
	P/B	0.54	0.90	0.87	1.16	1.58	1.91	1.07	1.36	1.06	1.11
	EV/Sales	11.14	10.70	8.87	11.26	11.94	13.65	9.06	9.24	8.18	7.39
	EV/FCF	(0.60)	(1.35)	(3.72)	(3.61)	(6.07)	(12.44)	(20.13)	9.49	35.15	73.65
Cash, $m
Cash, $m	Operating cash flow	(2)	13	25	36	35	69	77	68	70	74
	Capex	(151)	(252)	(152)	(257)	(219)	(196)	(138)	69	(38)	(59)
	Free cash flow	(153)	(240)	(127)	(220)	(184)	(127)	(62)	137	32	15
Balance, $m
Balance, $m	Working capital	(19)	(33)	(37)	(37)	(61)	(55)	(57)	(32)	(22)	(8)
	Total debt	29	165	282	356	526	519	642	589	635	656
	Net debt	8	158	277	348	515	506	627	582	626	644
	Shareholders’ equity	155	259	300	460	458	638	649	606	556	530
Returns, %
Returns, %	ROA	(4.34)	(0.50)	1.38	0.45	(0.78)	1.00	1.00	1.11	0.06	(0.97)
	ROIC	0.04	1.48	2.37	2.09	1.04	2.02	1.88	2.00	1.74	1.95
	ROE	(8.20)	(1.03)	3.75	1.12	(2.02)	2.50	2.34	2.68	0.16	(2.73)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
SBRA Sabra Healthcare REIT, Inc.	$4.8B	72.9×	27.3×	+24.70% (above 0%: growing)	n/m	−666.09% (below 0%: shrinking)	100.00%	(13.59%)	Compare
NHI National Health Investors, Inc.	$3.2B	18.7×	20.2×	+33.81% (above 0%: growing)	+45.57% (above 0%: growing)	+2,585.45% (above 0%: growing)	72.18%	41.09%	Compare
LTC LTC Properties, Inc.	$2.3B	15.5×	18.8×	+64.11% (above 0%: growing)	+72.73% (above 0%: growing)	−213.92% (below 0%: shrinking)	100.00%	31.24%	Compare
MPT Medical Properties Trust, Inc.	$1.9B	— (loss-making)	39.5×	+7.87% (above 0%: growing)	n/m	−15.15% (below 0%: shrinking)	95.68%	3.31%	Compare
DHC Diversified Healthcare Trust	$1.8B	— (loss-making)	8.4×	−4.53% (below 0%: shrinking)	n/m	−93.96% (below 0%: shrinking)	23.11%	(0.14%)	Compare
STRW Strawberry Fields REIT, Inc.	$716.3M	19.9×	19.3×	+5.78% (above 0%: growing)	0.00%	+55.53% (above 0%: growing)	89.67%	53.67%	Compare
UHT Universal Health Realty Income Trust	$521.8M	27.0×	31.2×	+0.49% (above 0%: growing)	+30.30% (above 0%: growing)	−69.28% (below 0%: shrinking)	94.29%	36.83%	Compare
XRN Chiron Real Estate Inc.	$494.3M	9.0×	— (loss-making)	+4.68% (above 0%: growing)	n/m	−18.02% (below 0%: shrinking)	100.00%	23.19%
CHCT Community Healthcare Trust Incorporated	$392.0M	20.3×	36.8×	+7.35% (above 0%: growing)	n/m	+35.09% (above 0%: growing)	81.22%	31.17%	Compare
Median of peers	$1.9B	20.1×	23.8×	+7.61%	+37.93%	−42.21%	91.98%	31.21%

All 16 Reit Healthcare Facilities stocks →

Chiron Real Estate Inc. (XRN) key facts

Strength: Chiron Real Estate Inc.’s revenue for fiscal 2025 (year ended December 2025) was $148.2 million, up 6.79% from fiscal 2024.
Chiron Real Estate Inc. (XRN) is a Reit Healthcare Facilities company in the Real Estate sector, listed on the New York Stock Exchange.
As of October 9, 2026, XRN traded at $33.59, a market capitalization of $494.3 million.
Chiron Real Estate Inc. pays an annual dividend of $2.46 per share, a yield of 7.31%, with a payout ratio of 66.1%.
Return on equity was −2.73% and debt-to-equity 0.93.
Its Piotroski F-score is 4 out of 9 for fiscal 2025.